Bristol Myers Squibb announced its first-quarter results before the market opened on Thursday. This time the news wasn't as good as investors would have preferred, with the big pharma stock slipping more than 3% in early trading. Here are the highlights from the Q1 update.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,